Refinement of chromosome 3p22.3 region and identification of a susceptibility gene for bipolar affective disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 2, 2013, Pages 163-168

  Secolin, Rodrigo ^a   Banzato, Claudio E M ^a   Mella, Lucas F B ^a   Santos, Marilza L ^a   Dalgalarrondo, Paulo ^a   Lopes Cendes, Iscia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Family based association studies; Genetics; ITGA9 gene; MicroRNA; Mood disorders; SNPs

Indexed keywords

ALPHA9 INTEGRIN; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; GLYCOPROTEIN; MEMBRANE PROTEIN; MICRORNA; NEUROTROPHIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BIPOLAR DISORDER; BIPOLAR I DISORDER; CHROMOSOME 3P; DNA SEQUENCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MANIA; MIXED ANXIETY AND DEPRESSION; NUCLEAR FAMILY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; BIPOLAR DISORDER; CHROMOSOMES, HUMAN, PAIR 3; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTEGRINS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 84874130507     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32127     Document Type: Article

References (32)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association Press. 886 p.
2. Barbosa IG, Huguet RB, Neves FS, Reis HJ, Bauer ME, Janka Z, Palotas A, Teixeira AL. 2011. Impaired nerve growth factor homeostasis in patients with bipolar disorder. World J Biol Psychiatry 12:228-232.
3. Barnett JH, Smoller JW. 2009. The genetics of bipolar disorder. Neuroscience 164:331-343.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Betel D, Wilson M, Gabow A, Marks DS, Sander C. 2008. The microRNA.org resource: Targets and expression. Nucleic Acids Res 36:D149-D153.
6. Breen G, Lewis CM, Vassos E, Pergadia ML, Blackwood DH, Boomsma DI, Penninx B, Sullivan PF, Pedroso I, Collier D, et al. 2011. Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression. Nat Genet 43:3-5; author reply 5.
7. Chen WM, Deng HW. 2001. A general and accurate approach for computing the statistical power of the transmission disequilibrium test for complex disease genes. Genet Epidemiol 21:53-67.
8. de Oliveira GS, Cereser KM, Fernandes BS, Kauer-Sant'Anna M, Fries GR, Stertz L, Aguiar B, Pfaffenseller B, Kapczinski F. 2009. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 43:1171-1174.
9. Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F. 2009. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord 11:663-671.
10. Fernandes BS, Gama CS, Kauer-Sant'Anna M, Lobato MI, Belmonte-de-Abreu P, Kapczinski F. 2009. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis. J Psychiatr Res 43:1200-1204.
11. Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F. 2011. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res 45:995-1004.
12. Goff LA, Davila J, Swerdel MR, Moore JC, Cohen RI, Wu H, Sun YE, Hart RP. 2009. Ago2 immunoprecipitation identifies predicted microRNAs in human embryonic stem cells and neural precursors. PLoS ONE 4:e7192.
13. Gordon D, Haynes C, Johnnidis C, Patel SB, Bowcock AM, Ott J. 2004. A transmission disequilibrium test for general pedigrees that is robust to the presence of random genotyping errors and any number of untyped parents. Eur J Hum Genet 12:752-761.
14. Grande I, Fries GR, Kunz M, Kapczinski F. 2010. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 7:243-250.
15. Hashimoto K. 2010. Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions. Psychiatry Clin Neurosci 64:341-357.
16. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. 2004. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9:406-416.
17. Kato T. 2007. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61:3-19.
18. Kozomara A, Griffiths-Jones S. 2011. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157.
19. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD, Steele CJ, Breuer R, Strohmaier J, Wendland JR, et al. 2010. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 42:128-131.
20. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266.
21. R Development Core Team. 2011. R: A language and environment for statistical computing. Version 2.12.2. Vienna: R Foundation for Statistical Computing.
22. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517.
23. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. 2006. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11:965-978.
24. Secolin R, Rocha CS, Torres FR, Santos ML, Maurer-Morelli CV, Santos NF, Lopes-Cendes I. 2008. LINKGEN: A new algorithm to process data in genetic linkage studies. Genomics 91:544-547.
25. Secolin R, Banzato CE, Oliveira MC, Bittar MF, Santos ML, Dalgalarrondo P, Lopes-Cendes I. 2010. Family-based association study for bipolar affective disorder. Psychiatr Genet 20:126-129.
26. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, et al. 2003. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75.
27. Staniszewska I, Sariyer IK, Lecht S, Brown MC, Walsh EM, Tuszynski GP, Safak M, Lazarovici P, Marcinkiewicz C. 2008. Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J Cell Sci 121:504-513.
28. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062-6067.
29. The Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661-678.
30. Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, Boudreau N, Sheppard D. 2007. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 282:15187-15196.
31. World Health Organization. 2008. The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press, Vol. vii, 146 p.
32. Young BA, Taooka Y, Liu S, Askins KJ, Yokosaki Y, Thomas SM, Sheppard D. 2001. The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol Biol Cell 12:3214-3225.